{
  "disease_name": "CLN3 disease",
  "orpha_code": "228346",
  "drugs": [
    {
      "name": "BRINEURA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/489549?name=228346&mode=orpha&region=",
      "regulatory_id": "489549",
      "orpha_substance_code": "ORPHA:216",
      "details": [
        "BRINEURA(Tradename                        - 30/05/2017)Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "BRINEURA(Tradename                        - 30/05/2017)",
        "(Tradename                        - 30/05/2017)",
        "Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/489546?name=228346&mode=orpha&region=&status=all",
          "text": "BRINEURA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/216",
          "text": "ORPHA:216 Neuronal ceroid lipofuscinosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/489549?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype rh.10 encoding the CLN2 gene",
      "substance_url": "/en/drug/substance/633481?name=228346&mode=orpha&region=&status=all",
      "substance_id": "633481",
      "regulatory_url": "/en/drug/regulatory/633482?name=228346&mode=orpha&region=",
      "regulatory_id": "633482",
      "orpha_substance_code": "ORPHA:216",
      "details": [
        "Adeno-associated viral vector serotype rh.10 encoding the CLN2 gene(Medicinal product                        - 11/10/2022)Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "Adeno-associated viral vector serotype rh.10 encoding the CLN2 gene(Medicinal product                        - 11/10/2022)",
        "(Medicinal product                        - 11/10/2022)",
        "Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/633481?name=228346&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype rh.10 encoding the CLN2 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/216",
          "text": "ORPHA:216 Neuronal ceroid lipofuscinosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/633482?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Tamoxifen citrate",
      "substance_url": "/en/drug/substance/489719?name=228346&mode=orpha&region=&status=all",
      "substance_id": "489719",
      "regulatory_url": "/en/drug/regulatory/628437?name=228346&mode=orpha&region=",
      "regulatory_id": "628437",
      "orpha_substance_code": "ORPHA:216",
      "details": [
        "Tamoxifen citrate(Medicinal product                        - 21/06/2022)Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "Tamoxifen citrate(Medicinal product                        - 21/06/2022)",
        "(Medicinal product                        - 21/06/2022)",
        "Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/489719?name=228346&mode=orpha&region=&status=all",
          "text": "Tamoxifen citrate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/216",
          "text": "ORPHA:216 Neuronal ceroid lipofuscinosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/628437?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector encoding for the human palmitoyl-protein thioesterase 1 gene",
      "substance_url": "/en/drug/substance/627814?name=228346&mode=orpha&region=&status=all",
      "substance_id": "627814",
      "regulatory_url": "/en/drug/regulatory/627817?name=228346&mode=orpha&region=",
      "regulatory_id": "627817",
      "orpha_substance_code": "ORPHA:216",
      "details": [
        "Autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector encoding for the human palmitoyl-protein thioesterase 1 gene(Medicinal product                        - 19/07/2021)Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "Autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector encoding for the human palmitoyl-protein thioesterase 1 gene(Medicinal product                        - 19/07/2021)",
        "(Medicinal product                        - 19/07/2021)",
        "Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/627814?name=228346&mode=orpha&region=&status=all",
          "text": "Autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector encoding for the human palmitoyl-protein thioesterase 1 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/216",
          "text": "ORPHA:216 Neuronal ceroid lipofuscinosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/627817?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Adeno-associated virus serotype 9 expressing human CLN5",
      "substance_url": "/en/drug/substance/627530?name=228346&mode=orpha&region=&status=all",
      "substance_id": "627530",
      "regulatory_url": "/en/drug/regulatory/627533?name=228346&mode=orpha&region=",
      "regulatory_id": "627533",
      "orpha_substance_code": "ORPHA:216",
      "details": [
        "Adeno-associated virus serotype 9 expressing human CLN5(Medicinal product                        - 21/06/2021)Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "Adeno-associated virus serotype 9 expressing human CLN5(Medicinal product                        - 21/06/2021)",
        "(Medicinal product                        - 21/06/2021)",
        "Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/627530?name=228346&mode=orpha&region=&status=all",
          "text": "Adeno-associated virus serotype 9 expressing human CLN5",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/216",
          "text": "ORPHA:216 Neuronal ceroid lipofuscinosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/627533?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Miglustat",
      "substance_url": "/en/drug/substance/65934?name=228346&mode=orpha&region=&status=all",
      "substance_id": "65934",
      "regulatory_url": "/en/drug/regulatory/604904?name=228346&mode=orpha&region=",
      "regulatory_id": "604904",
      "orpha_substance_code": "ORPHA:216",
      "details": [
        "Miglustat(Medicinal product                        - 19/10/2020)Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "Miglustat(Medicinal product                        - 19/10/2020)",
        "(Medicinal product                        - 19/10/2020)",
        "Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/65934?name=228346&mode=orpha&region=&status=all",
          "text": "Miglustat",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/216",
          "text": "ORPHA:216 Neuronal ceroid lipofuscinosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/604904?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN6 gene",
      "substance_url": "/en/drug/substance/570598?name=228346&mode=orpha&region=&status=all",
      "substance_id": "570598",
      "regulatory_url": "/en/drug/regulatory/570600?name=228346&mode=orpha&region=",
      "regulatory_id": "570600",
      "orpha_substance_code": "ORPHA:216",
      "details": [
        "recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN6 gene(Medicinal product                        - 21/08/2019)Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN6 gene(Medicinal product                        - 21/08/2019)",
        "(Medicinal product                        - 21/08/2019)",
        "Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/570598?name=228346&mode=orpha&region=&status=all",
          "text": "recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN6 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/216",
          "text": "ORPHA:216 Neuronal ceroid lipofuscinosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/570600?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "recombinant self-complementary adeno-associated viral vector serotype 9 (AAV9) containing the human CLN3 gene",
      "substance_url": "/en/drug/substance/570594?name=228346&mode=orpha&region=&status=all",
      "substance_id": "570594",
      "regulatory_url": "/en/drug/regulatory/570596?name=228346&mode=orpha&region=",
      "regulatory_id": "570596",
      "orpha_substance_code": "ORPHA:216",
      "details": [
        "recombinant self-complementary adeno-associated viral vector serotype 9 (AAV9) containing the human CLN3 gene(Medicinal product                        - 21/08/2019)Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "recombinant self-complementary adeno-associated viral vector serotype 9 (AAV9) containing the human CLN3 gene(Medicinal product                        - 21/08/2019)",
        "(Medicinal product                        - 21/08/2019)",
        "Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/570594?name=228346&mode=orpha&region=&status=all",
          "text": "recombinant self-complementary adeno-associated viral vector serotype 9 (AAV9) containing the human CLN3 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/216",
          "text": "ORPHA:216 Neuronal ceroid lipofuscinosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/570596?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype 9 containing the human CLN1 gene",
      "substance_url": "/en/drug/substance/527480?name=228346&mode=orpha&region=&status=all",
      "substance_id": "527480",
      "regulatory_url": "/en/drug/regulatory/527484?name=228346&mode=orpha&region=",
      "regulatory_id": "527484",
      "orpha_substance_code": "ORPHA:216",
      "details": [
        "Adeno-associated viral vector serotype 9 containing the human CLN1 gene(Medicinal product                        - 25/05/2018)Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "Adeno-associated viral vector serotype 9 containing the human CLN1 gene(Medicinal product                        - 25/05/2018)",
        "(Medicinal product                        - 25/05/2018)",
        "Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/527480?name=228346&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype 9 containing the human CLN1 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/216",
          "text": "ORPHA:216 Neuronal ceroid lipofuscinosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/527484?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Gemfibrozil",
      "substance_url": "/en/drug/substance/511210?name=228346&mode=orpha&region=&status=all",
      "substance_id": "511210",
      "regulatory_url": "/en/drug/regulatory/511211?name=228346&mode=orpha&region=",
      "regulatory_id": "511211",
      "orpha_substance_code": "ORPHA:216",
      "details": [
        "Gemfibrozil(Medicinal product                        - 21/03/2018)Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "Gemfibrozil(Medicinal product                        - 21/03/2018)",
        "(Medicinal product                        - 21/03/2018)",
        "Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/511210?name=228346&mode=orpha&region=&status=all",
          "text": "Gemfibrozil",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/216",
          "text": "ORPHA:216 Neuronal ceroid lipofuscinosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/511211?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Recombinant human tripeptidyl-peptidase 1",
      "substance_url": "/en/drug/substance/323236?name=228346&mode=orpha&region=&status=all",
      "substance_id": "323236",
      "regulatory_url": "/en/drug/regulatory/331030?name=228346&mode=orpha&region=",
      "regulatory_id": "331030",
      "orpha_substance_code": "ORPHA:216",
      "details": [
        "Recombinant human tripeptidyl-peptidase 1(Medicinal product                        - 12/03/2013)Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "Recombinant human tripeptidyl-peptidase 1(Medicinal product                        - 12/03/2013)",
        "(Medicinal product                        - 12/03/2013)",
        "Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/323236?name=228346&mode=orpha&region=&status=all",
          "text": "Recombinant human tripeptidyl-peptidase 1",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/216",
          "text": "ORPHA:216 Neuronal ceroid lipofuscinosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/331030?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Trehalose",
      "substance_url": "/en/drug/substance/418127?name=228346&mode=orpha&region=&status=all",
      "substance_id": "418127",
      "regulatory_url": "/en/drug/regulatory/604892?name=228346&mode=orpha&region=",
      "regulatory_id": "604892",
      "orpha_substance_code": "ORPHA:216",
      "details": [
        "Trehalose(Medicinal product                        - 19/10/2020)Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "Trehalose(Medicinal product                        - 19/10/2020)",
        "(Medicinal product                        - 19/10/2020)",
        "Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/418127?name=228346&mode=orpha&region=&status=all",
          "text": "Trehalose",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/216",
          "text": "ORPHA:216 Neuronal ceroid lipofuscinosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/604892?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN3 gene",
      "substance_url": "/en/drug/substance/485379?name=228346&mode=orpha&region=&status=all",
      "substance_id": "485379",
      "regulatory_url": "/en/drug/regulatory/485380?name=228346&mode=orpha&region=",
      "regulatory_id": "485380",
      "orpha_substance_code": "ORPHA:216",
      "details": [
        "Recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN3 gene(Medicinal product                        - 12/12/2016)Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "Recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN3 gene(Medicinal product                        - 12/12/2016)",
        "(Medicinal product                        - 12/12/2016)",
        "Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/485379?name=228346&mode=orpha&region=&status=all",
          "text": "Recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN3 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/216",
          "text": "ORPHA:216 Neuronal ceroid lipofuscinosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/485380?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Brivaracetam",
      "substance_url": "/en/drug/substance/94738?name=228346&mode=orpha&region=&status=all",
      "substance_id": "94738",
      "regulatory_url": "/en/drug/regulatory/133994?name=228346&mode=orpha&region=",
      "regulatory_id": "133994",
      "orpha_substance_code": "ORPHA:98261",
      "details": [
        "Brivaracetam(Medicinal product                        - 26/08/2005)Disease(s) concernedORPHA:98261 Progressive myoclonic epilepsy",
        "Brivaracetam(Medicinal product                        - 26/08/2005)",
        "(Medicinal product                        - 26/08/2005)",
        "Disease(s) concernedORPHA:98261 Progressive myoclonic epilepsy",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/94738?name=228346&mode=orpha&region=&status=all",
          "text": "Brivaracetam",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/98261",
          "text": "ORPHA:98261 Progressive myoclonic epilepsy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/133994?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "LIBERVANT",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/673903?name=228346&mode=orpha&region=",
      "regulatory_id": "673903",
      "orpha_substance_code": "ORPHA:166463",
      "details": [
        "LIBERVANT(Tradename                        - 26/04/2024)Disease(s) concernedORPHA:166463 Epilepsy syndrome",
        "LIBERVANT(Tradename                        - 26/04/2024)",
        "(Tradename                        - 26/04/2024)",
        "Disease(s) concernedORPHA:166463 Epilepsy syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/673890?name=228346&mode=orpha&region=&status=all",
          "text": "LIBERVANT",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/166463",
          "text": "ORPHA:166463 Epilepsy syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/673903?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "BRINEURA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/529817?name=228346&mode=orpha&region=",
      "regulatory_id": "529817",
      "orpha_substance_code": "ORPHA:216",
      "details": [
        "BRINEURA(Tradename                        - 27/04/2017)Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "BRINEURA(Tradename                        - 27/04/2017)",
        "(Tradename                        - 27/04/2017)",
        "Disease(s) concernedORPHA:216 Neuronal ceroid lipofuscinosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/489546?name=228346&mode=orpha&region=&status=all",
          "text": "BRINEURA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/216",
          "text": "ORPHA:216 Neuronal ceroid lipofuscinosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/529817?name=228346&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T05:59:43.064913",
  "run_number": 1,
  "total_drugs_found": 16,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=CLN3+disease&orphaCode=228346&name=228346&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "CLN3 disease",
    "orphaCode": "228346",
    "name": "228346",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}